Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study.

Schlam I, Smith DM, Peer C, Sissung T, Schmidt KT, Tan M, Chitalia A, Bishopric NH, Steinberg S, Choo-Wosoba H, Napoli G, Gallagher C, Ashai N, Whitaker K, Mainor C, Tiwari S, Swanson N, Malloy S, Isaacs C, Figg WD, Swain SM

Open source

DOI: 10.1038/s41523-024-00692-w
Published: 2024 Sep 30
Container: NPJ breast cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41523-024-00692-w,
  title = {Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study.},
  author = {Schlam I and Smith DM and Peer C and Sissung T and Schmidt KT and Tan M and Chitalia A and Bishopric NH and Steinberg S and Choo-Wosoba H and Napoli G and Gallagher C and Ashai N and Whitaker K and Mainor C and Tiwari S and Swanson N and Malloy S and Isaacs C and Figg WD and Swain SM},
  year = {2024},
  journal = {NPJ breast cancer},
  doi = {10.1038/s41523-024-00692-w},
  url = {https://doi.org/10.1038/s41523-024-00692-w}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study.
AU  - Schlam I
AU  - Smith DM
AU  - Peer C
AU  - Sissung T
AU  - Schmidt KT
AU  - Tan M
AU  - Chitalia A
AU  - Bishopric NH
AU  - Steinberg S
AU  - Choo-Wosoba H
AU  - Napoli G
AU  - Gallagher C
AU  - Ashai N
AU  - Whitaker K
AU  - Mainor C
AU  - Tiwari S
AU  - Swanson N
AU  - Malloy S
AU  - Isaacs C
AU  - Figg WD
AU  - Swain SM
PY  - 2024
JO  - NPJ breast cancer
DO  - 10.1038/s41523-024-00692-w
UR  - https://doi.org/10.1038/s41523-024-00692-w
ER  -

APA

I, S., DM, S., C, P., T, S., KT, S., M, T., A, C., NH, B., S, S., H, C., G, N., C, G., N, A., K, W., C, M., S, T., N, S., S, M., C, I., WD, F., & SM, S. (2024). Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study.. NPJ breast cancer. https://doi.org/10.1038/s41523-024-00692-w

Source records

pubmed · retrieved 2026-09-26T03:27:15.153Z